HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

506.075

-10.940-2.12%

Number of Gainers:9

Number of Losers:21

Number of Flat:3

PE:- -

High:516.490

Open:516.490

Low:500.597

Close:517.015

Volume:149.97M

Turnover:4.87B

Market Cap:324.25B

Float Cap:288.12B

Loading ...

BAIYUNSHAN PH Subsidiary Secures Pharmaceutical Registration Certificate from Macau Health Regulator

Nancheng County Market Watch Intensifies Medical Supply Checks at Village Clinics

HBM Holdings Schedules Board Meeting to Review Interim Results

Dual-Listed Stock Premium Rankings: August 17 Closing Data

Fictitious Profits Equated to 157% of Total Reported Income: A 2023 Loss Was Masked as Gains for This Company, Affected Investors May Be Eligible for Claims

HEARTCARE-B Plans A-Share Issuance and STAR Market Listing

BASECARE-B expects first-half revenue of 126-131 million yuan, up 24% to 29% year-on-year

Suzhou Basecare Medical Expects H1 Revenue to Rise 24%-29% Y/Y

THOMSON REUTERS

Suzhou Basecare Expects H1 Loss Attributable to Shareholders to Narrow 39.5%-43.2% to RMB 69 Million-RMB 73.5 Million

CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult

THOMSON REUTERS

CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review

Profit Warning Triggers Sharp Decline in ACOTEC-B Stock as Key U.S. Clinical Trial Faces Hurdles

Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof

Fund investors surprised as institutions sell into strength, with popular healthcare and medical ETFs seeing roughly 3 billion yuan in net outflows recently

HEARTCARE-B (06609) Proposes A-Share Issuance and Listing on Shanghai STAR Market

Shanghai HeartCare Proposes Bylaw Amendments Ahead of Planned Shanghai STAR Listing

MicroPort CardioFlow Schedules Board Meeting to Review Interim Results, Consider Dividend

Penalty on Nanyangxin Pharmaceutical Fuels Ongoing Investor Claims

Ocumension Therapeutics Schedules Board Meeting to Review Interim Results, Consider Dividend

Everest Medicines Files Board, Board Committee Member List with Disclosure Responsibilities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1574/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":506.0749,"timestamp":1787299686774,"preClose":517.0147,"halted":0,"volume":149966252,"delay":0,"changeRate":-0.02116,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-10.939819,"latestTime":"08-21 16:00:00","open":516.49023,"high":516.49023,"low":500.59692,"amount":4865243342.5,"amplitude":0.030741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":4.109535,"peRate":-81.157718,"turnoverRate":0.005372,"increases":11,"decrements":20,"flats":2,"marketCap":324245256080,"floatMarketCap":288118014384},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":516.49023,"amplitude":0.030741,"preClose":517.0147,"low":500.59692,"pbRate":"4.109535","latestPrice":506.0749,"volume":149966252,"delay":0,"open":516.49023,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":518.327,"twentyDayClose":498.407,"sixtyDayClose":542.586,"secType":"PLATE","market":"HK","turnoverRate":0.005372,"peRate":-81.157718,"marketCap":324245256080,"floatMarketCap":288118014384,"timestamp":1787299686774,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":9,"down":21,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1165773378","title":"BAIYUNSHAN PH Subsidiary Secures Pharmaceutical Registration Certificate from Macau Health Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1165773378","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165773378?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:50","pubTimestamp":1786960219,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) has announced a key regulatory milestone for its controlled subsidiary. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited confirmed that its subsidiary, Guangzhou...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0175","BK1574","BK0070","BK1191","BK0183","BK0196","BK0096","BK1606","BK0028","BK0012","600332","BK1515","BK0097","BK1521","01477","00874","BK1197","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199985936","title":"Nancheng County Market Watch Intensifies Medical Supply Checks at Village Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=1199985936","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199985936?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:03","pubTimestamp":1786957404,"startTime":"0","endTime":"0","summary":"The Market Supervision Administration of Nancheng County, Jiangxi Province, has recently ramped up enforcement efforts, conducting dedicated inspections of pharmaceuticals and medical devices at...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","LNGR","AGNG","09996","BK1574","MEDX","PTH","IEIH","LGHT","HART","RSPH","GDOC","MDEV","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483275","title":"HBM Holdings Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483275?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:39","pubTimestamp":1786955976,"startTime":"0","endTime":"0","summary":"HBM Holdings schedules board meeting to review interim resultsHBM Holdings schedules a board meeting for Aug. 27, 2026 to review interim results for the six months ended June 30, 2026.Disclaimer:This ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9k5rrC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02142","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191703490","title":"Dual-Listed Stock Premium Rankings: August 17 Closing Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1191703490","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191703490?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:21","pubTimestamp":1786954907,"startTime":"0","endTime":"0","summary":"As of the close on August 17, the top three positions by A-H share premium are held by NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and FUDANZHANGJIANG (01349), recording premiums of 993.12%,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNQ40.USD","BK1209","LU0348814723.USD","02846","LU0620787316.HKD","LU0737861699.HKD","LU0516422440.USD","LU1675838814.USD","IE00B031J352.USD","00916","LU0455707207.USD","LU2008162690.USD","LU0327786744.USD","LU0871576103.HKD","LU0648948544.HKD","LU2226246903.HKD","LU1769817179.HKD","LU0828237940.HKD","LU0329678170.USD","LU0054450605.USD","BK1576","LU0328353924.USD","BK1183","HK0000320264.USD","SG9999011746.SGD","02218","00895","LU0823040885.USD","LU1282648689.USD","BK1161","LU2476274720.SGD","BK1198","LU1769817096.USD","LU0039217434.USD","BK1141","LU0164865239.USD","BK1594","BK1607","LU1688375341.USD","LU0128522157.USD","03130","LU1328277881.USD","LU1244550494.USD","SG9999002828.SGD","EWH","LU0106252389.USD","BK1149","LU1046422090.SGD","06655","03328","LU0880133367.SGD","BK1610","LU1282649141.HKD","02359","BK1135","02865","LU0791591158.USD","LU1282649810.SGD","LU2125910500.SGD","LU0359201885.HKD","BK1614","BK1163","SG9999001093.SGD","IE00BMCWC346.EUR","LU0456827905.SGD","LU0501845795.SGD","BK1214","LU1504937902.USD","IE00B29SXG58.USD","02691","BK1171","SG9999001226.SGD","LU0543330566.HKD","LU1251922891.USD","LU0149721374.USD","BK1537","LU0918141887.USD","LU0886674414.USD","LU0431992006.USD","LU1152091168.USD","LU0072913022.USD","HK0000252160.HKD","LU0029875118.USD","HK0000306685.HKD","LU0348827113.USD","LU0572944931.SGD","LU0640798160.USD","BK1574","LU0561508036.HKD","LU0791590937.USD","01989","03200","LU0210526637.USD","159982","BK1554","HK0000500386.USD","LU0348805143.USD","LU0163747925.USD","BK1505","LU1988902786.USD","LU1770034418.SGD","LU0096374516.USD","BK1551","LU0417516738.SGD","LU1831875114.USD","LU2778985437.USD","BK1558","LU2264538146.SGD","LU2097828474.EUR","LU0320764755.SGD","LU0516423174.USD","BK1521","BK1140","LU0307460666.USD","BK1122","LU1211504680.USD","LU0266512127.USD","00187","LU0043850808.USD","LU0231483743.USD","IE0031814852.USD","IE00B3M56506.USD","LU0531971595.HKD","BK1507","LU0348766576.USD","BK1105","BK1560","LU0149534421.HKD","07233","LU0229945570.USD","LU0463099449.HKD","LU0737861772.HKD","LU2399975544.HKD","LU0228659784.USD","LU0589944569.HKD","82846","01033","LU0082770016.SGD","LU1366334578.USD","LU0082770016.USD","LU0244354667.USD","IE00BGHQDM52.EUR","LU1282649067.USD","LU0345780281.USD","02899","BK1514","01108","SG9999004220.SGD","LU1242518857.USD","LU1808992512.USD","LU2476274308.USD","BK1202","LU0469268626.HKD","BK1190","03750","LU0117841782.USD","03308","HK0000306701.USD","LU0314109678.HKD","LU0348767384.USD","LU1880383440.USD","LU0051755006.USD","LU1794554557.SGD","HK0000252152.HKD","IE00BVYPNP33.GBP","LU2097828805.USD","BK1147","HK0000352382.USD","LU0672654166.SGD","LU0708995583.HKD","BK1515","LU0326950275.SGD","LU0254981946.USD","HK0000320223.HKD","BK1552","01349","LU0540923850.HKD","LU2294711473.HKD","BK1237","LU0348735423.USD","LU0821914370.USD","LU2039709279.SGD","03143","LU1224709979.USD","LU0531970944.HKD","LU0868486357.SGD","03188","LU0516423091.SGD","LU0488056044.USD","LU0165289439.USD","06951","BK1170","LU0214875030.USD","LU0164939612.USD","LU0348788117.USD","IE0034224299.USD","LU1115378108.SGD","LU0359202008.SGD","BK1592","LU0320764599.SGD","LU0052750758.USD","LU1064131342.USD","LU1188198961.HKD","HK0001040143.USD","02475","LU0509642566.USD","LU0048580855.USD","LU0979878070.USD","00981","LU0140636845.USD","LU0516422366.SGD","BK1191","SG9999014674.SGD","02338","LU0345780521.USD","LU0456854461.SGD","BK1526","IE00BZ08YS42.EUR","06185","IE00B5MMRT66.SGD","LU1008478684.HKD","HK0000352291.HKD","00042","00568","LU1720050803.USD","LU0384037296.USD","LU2097828631.EUR","02827","LU1807302812.USD","LU0370786039.SGD","BK1223","01057","LU0823426480.USD","LU0823426308.USD","06869","IE00BZ08YR35.GBP","03678","IE0008369823.USD","LU2097828557.USD","LU1960683339.HKD","LU0588546209.SGD","LU0634319403.HKD","LU0266512473.USD","BK1506","LU1105468828.SGD","LU0797268264.HKD","03986","LU2177674079.SGD","IE0032431581.USD","06693","BK1546","06745","BK1562","LU0417516902.SGD","LU0502904849.HKD","IE00B543WZ88.USD","LU0061477393.USD","IE0008368742.USD","LU3063872942.SGD","03968","LU0607220059.USD","LU1242518931.SGD","IE00BF5LJ272.USD","LU0449515922.USD","00553","LU0359201612.USD","LU0181495838.USD","LU0543330483.HKD","LU1244550577.SGD","83130","LU1961090484.USD","BK1544","LU0516422952.EUR","LU0918141705.HKD","LU0315179316.USD","00300","LU0828238088.HKD","LU0049853897.USD","IE00B0169L03.USD","IE00B031HY20.USD","LU0269904917.USD","LU1719994722.HKD","BK1564","BK1231","LU0329678337.USD","LU1366334651.USD","SG9999002463.SGD","IE00BYV24P56.USD","LU0348816934.USD","BK1533","BK1522","LU0211977185.USD","LU2242644610.SGD","399300","LU0593848301.USD","01812","LU0228367735.SGD","LU1993786604.SGD","BK1154","LU1303224171.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU0348825331.USD","LU0890818403.SGD","LU2097828714.EUR","LU1048596156.SGD","83188","LU0287142896.SGD","LU1813983027.USD","SG9999006597.SGD","06613","LU0106959298.USD","BK1249","LU1481107354.HKD","BK1523","LU0862451753.SGD","LU1023057109.AUD","LU0164880469.USD","LU1244550221.USD","BK1110","LU1880383366.USD","LU0449509016.USD","LU0828237510.HKD","LU2045819591.USD","LU1226287529.USD","BK1116","HK0001040168.HKD","BK1144","LU0067412154.USD","BK1583","LU0456846285.SGD","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117517726","title":"Fictitious Profits Equated to 157% of Total Reported Income: A 2023 Loss Was Masked as Gains for This Company, Affected Investors May Be Eligible for Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1117517726","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117517726?lang=en_us&edition=fundamental","pubTime":"2026-08-17 14:40","pubTimestamp":1786948853,"startTime":"0","endTime":"0","summary":"Investors who have incurred losses can register their claims with the platform at: http://wq.finance.sina.com.cn/. Follow @Sina Securities on WeChat, search for Sina Securities and Funds on WeChat,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119902218","title":"HEARTCARE-B Plans A-Share Issuance and STAR Market Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1119902218","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119902218?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:50","pubTimestamp":1786927830,"startTime":"0","endTime":"0","summary":"HEARTCARE-B (06609) has announced that its board of directors has recommended applying to relevant Chinese regulatory authorities for the issuance and allotment of no more than 7,025,592 A-shares of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KSTR","02827","83188","83130","IPOS","BK1574","03188","BK1147","82846","BK1587","06609","03130","159982","07233","02846","399300","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140989141","title":"BASECARE-B expects first-half revenue of 126-131 million yuan, up 24% to 29% year-on-year","url":"https://stock-news.laohu8.com/highlight/detail?id=1140989141","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140989141?lang=en_us&edition=fundamental","pubTime":"2026-08-16 19:10","pubTimestamp":1786878619,"startTime":"0","endTime":"0","summary":"BASECARE-B (02170) has announced its financial projections for the six months ending June 30, 2026. The company anticipates revenue of approximately 126 million yuan to 131 million yuan, representing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1597","BK1222","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659723221","title":"Suzhou Basecare Medical Expects H1 Revenue to Rise 24%-29% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2659723221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659723221?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:58","pubTimestamp":1786877897,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nL4N44D01U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1222","BK1574","BK1597","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659172395","title":"Suzhou Basecare Expects H1 Loss Attributable to Shareholders to Narrow 39.5%-43.2% to RMB 69 Million-RMB 73.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659172395","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659172395?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:49","pubTimestamp":1786877343,"startTime":"0","endTime":"0","summary":"Suzhou Basecare expects H1 loss attributable to shareholders to narrow 39.5%-43.2% to RMB 69 million-RMB 73.5 millionSuzhou Basecare guided for revenue of RMB 125.7 million to RMB 130.8 million for H1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nNDL2xPyl2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","02170","BK1574","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659740901","title":"CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult","url":"https://stock-news.laohu8.com/highlight/detail?id=2659740901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659740901?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:14","pubTimestamp":1786875256,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nL4N44D01L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1191","06185","688185","BK1515","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126831454","title":"CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1126831454","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126831454?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:14","pubTimestamp":1786875254,"startTime":"0","endTime":"0","summary":"CanSino Biologics Inc (HKEX: 06185) announced that its New Drug Application (NDA) for the adsorbed acellular pertussis (five-component) diphtheria-tetanus-pertussis combined vaccine for individuals...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","06185","BK1515","BK1161","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129722256","title":"Profit Warning Triggers Sharp Decline in ACOTEC-B Stock as Key U.S. Clinical Trial Faces Hurdles","url":"https://stock-news.laohu8.com/highlight/detail?id=1129722256","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129722256?lang=en_us&edition=fundamental","pubTime":"2026-08-16 15:10","pubTimestamp":1786864228,"startTime":"0","endTime":"0","summary":"A profit warning from ACOTEC-B (06669) sent shockwaves through the market, with its stock price plunging over 15% in a single day. The company disclosed on August 12 that it expects a net loss of up...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","06669","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121433031","title":"Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof","url":"https://stock-news.laohu8.com/highlight/detail?id=1121433031","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121433031?lang=en_us&edition=fundamental","pubTime":"2026-08-16 11:10","pubTimestamp":1786849841,"startTime":"0","endTime":"0","summary":"Despite a rebound and valuation repair in the innovative drug sector since August, driven by oversold conditions, profit-taking and divergent stock performances following earnings results suggest...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1574","159992","MEDX","BK1161","06978","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107513118","title":"Fund investors surprised as institutions sell into strength, with popular healthcare and medical ETFs seeing roughly 3 billion yuan in net outflows recently","url":"https://stock-news.laohu8.com/highlight/detail?id=1107513118","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107513118?lang=en_us&edition=fundamental","pubTime":"2026-08-15 12:10","pubTimestamp":1786767041,"startTime":"0","endTime":"0","summary":"Major indices showed mixed performance this week, with combined net outflows from Shanghai and Shenzhen stock ETFs and cross-border ETFs reaching 59.654 billion yuan. By sector theme, semiconductor...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1574","159828","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122094650","title":"HEARTCARE-B (06609) Proposes A-Share Issuance and Listing on Shanghai STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1122094650","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122094650?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:58","pubTimestamp":1786719494,"startTime":"0","endTime":"0","summary":"The company has announced a board proposal to apply to relevant Chinese regulatory authorities for the issuance and placement of no more than 7,025,592 A-shares. The plan also includes seeking...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KSTR","02827","83188","83130","IPOS","BK1574","03188","BK1147","82846","BK1587","06609","03130","159982","07233","02846","399300","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140696","title":"Shanghai HeartCare Proposes Bylaw Amendments Ahead of Planned Shanghai STAR Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140696?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:50","pubTimestamp":1786719025,"startTime":"0","endTime":"0","summary":"Shanghai HeartCare proposes bylaw amendments ahead of planned Shanghai STAR listingShanghai HeartCare outlined planned bylaw amendments to align its articles with A-share listing requirements for Shan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLbW677C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143376","title":"MicroPort CardioFlow Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143376?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:43","pubTimestamp":1786704209,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow schedules board meeting to review interim results, consider dividendMicroPort CardioFlow Medtech will hold a board meeting on Aug. 26, 2026.Interim results for the six months ende","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3bT5NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1583","BK1589","02160","00853","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159362056","title":"Penalty on Nanyangxin Pharmaceutical Fuels Ongoing Investor Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1159362056","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159362056?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:41","pubTimestamp":1786700483,"startTime":"0","endTime":"0","summary":"Investors who have suffered losses can register their claims on the Sina Investor Rights Protection Platform: http://wq.finance.sina.com.cn/. You can find us by following @Sina Securities on Weibo,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659511731","title":"Ocumension Therapeutics Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659511731","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659511731?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:23","pubTimestamp":1786699387,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics schedules board meeting to review interim results, consider dividendOcumension Therapeutics scheduled a board meeting for Aug. 28, 2026.Directors will review interim results fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL55vYzs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659111211","title":"Everest Medicines Files Board, Board Committee Member List with Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659111211","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659111211?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:06","pubTimestamp":1786698405,"startTime":"0","endTime":"0","summary":"Everest Medicines files board, board committee member list with disclosure responsibilitiesEverest Medicines updated its board and committee roster, naming Wu Yifang as chairman, Luo Yongqing as CEO, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5JhNqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":9,"totalSize":286,"code":"91000000","status":"200"}]}}